Article · Volume 4, Issue 3 · pp. 221–222
Reply to “Good! is it the best ???
Aditi Chaturvedi1, Yogendra Singh2, Harish Chaturvedi3, Vijay Thawani4, Sakshi4, Deepak Parihar4
- 1Department of Pharmacology, Veer Chandra Singh Garhwali Medical College and Research Institute, Srikot, India.
- 2Department of Cardiology, Fortis Escorts Heart Institute, New Delhi, India.
- 3Department of Anatomy, Veer Chandra Singh Garhwali Medical College and Research Institute, Srikot, India.
- 4Himalyan Institute of Medical Sciences, Dehradun, Uttarakhand, India.
Abstract
The questions that were put forth to the patients were similar to those that were followed in the ERICA trial, i.e., patients were evaluated for average frequency of self‑reported anginal episodes during the treatment phase, changes in sublingual nitroglycerine use, heart rate, blood pressure, and adverse events.[3] Most of the patients were not taking sublingual nitroglycerine by the end of the study except two patients in the ivabradine group. Publishing questionnaire used in the study is a decision of the journal. If you want and request, we are willing to share it with you in the best interest of research.
Keywords: Letter to the Editor
The full text of this article is available as a PDF. Open the PDF.